TY - JOUR
T1 - Monitoring Keap1-Nrf2 interactions in single live cells
AU - Baird, Liam
AU - Swift, Sam
AU - Llères, David
AU - Dinkova-Kostova, Albena T.
N1 - Funding Information:
We thank Stephen M. Keyse, John D. Hayes and Angus I. Lamond (University of Dundee) for helpful discussions. We are very grateful to Michael McMahon (University of Dundee), Masayuki Yamamoto and Takafumi Suzuki (Tohoku University, Japan) for kind gifts of plasmids, Young-Hoon Ahn and Philip A. Cole (Johns Hopkins University) for STCA. We acknowledge the financial support of the Medical Research Council and Cancer Research UK ( C20953/A10270 ).
Publisher Copyright:
© 2014 The Authors.
PY - 2014
Y1 - 2014
N2 - The transcription factor NF-E2 p45-related factor 2 (Nrf2) and its negative regulator Kelch-like ECH associated protein 1 (Keap1) control the expression of nearly 500 genes with diverse cytoprotective functions. Keap1, a substrate adaptor protein for Cullin3/Rbx1 ubiquitin ligase, normally continuously targets Nrf2 for degradation, but loses this ability in response to electrophiles and oxidants (termed inducers). Consequently, Nrf2 accumulates and activates transcription of its downstream target genes. Many inducers are phytochemicals, and cruciferous vegetables represent one of the richest sources of inducer activity among the most commonly used edible plants. Here we summarize the discovery of the isothiocyanate sulforaphane as a potent inducer which reacts with cysteine sensors of Keap1, leading to activation of Nrf2. We then describe the development of a quantitative Förster resonance energy transfer (FRET)-based methodology combined with multiphoton fluorescence lifetime imaging microscopy (FLIM) to investigate the interactions between Keap1 and Nrf2 in single live cells, and the effect of sulforaphane, and other cysteine-reactive inducers, on the dynamics of the Keap1-Nrf2 protein complex. We present the experimental evidence for the "cyclic sequential attachment and regeneration" or "conformation cycling" model of Keap1-mediated Nrf2 degradation. Finally, we discuss the implications of this mode of regulation of Nrf2 for achieving a fine balance under normal physiological conditions, and the consequences and mechanisms of disrupting this balance for tumor biology.
AB - The transcription factor NF-E2 p45-related factor 2 (Nrf2) and its negative regulator Kelch-like ECH associated protein 1 (Keap1) control the expression of nearly 500 genes with diverse cytoprotective functions. Keap1, a substrate adaptor protein for Cullin3/Rbx1 ubiquitin ligase, normally continuously targets Nrf2 for degradation, but loses this ability in response to electrophiles and oxidants (termed inducers). Consequently, Nrf2 accumulates and activates transcription of its downstream target genes. Many inducers are phytochemicals, and cruciferous vegetables represent one of the richest sources of inducer activity among the most commonly used edible plants. Here we summarize the discovery of the isothiocyanate sulforaphane as a potent inducer which reacts with cysteine sensors of Keap1, leading to activation of Nrf2. We then describe the development of a quantitative Förster resonance energy transfer (FRET)-based methodology combined with multiphoton fluorescence lifetime imaging microscopy (FLIM) to investigate the interactions between Keap1 and Nrf2 in single live cells, and the effect of sulforaphane, and other cysteine-reactive inducers, on the dynamics of the Keap1-Nrf2 protein complex. We present the experimental evidence for the "cyclic sequential attachment and regeneration" or "conformation cycling" model of Keap1-mediated Nrf2 degradation. Finally, we discuss the implications of this mode of regulation of Nrf2 for achieving a fine balance under normal physiological conditions, and the consequences and mechanisms of disrupting this balance for tumor biology.
KW - Cytoprotective enzymes
KW - FLIM
KW - FRET
KW - Keap1
KW - Nrf2
KW - Sulforaphane
UR - http://www.scopus.com/inward/record.url?scp=84918811379&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84918811379&partnerID=8YFLogxK
U2 - 10.1016/j.biotechadv.2014.03.004
DO - 10.1016/j.biotechadv.2014.03.004
M3 - Review article
C2 - 24681086
AN - SCOPUS:84918811379
SN - 0734-9750
VL - 32
SP - 1133
EP - 1144
JO - Biotechnology Advances
JF - Biotechnology Advances
IS - 6
ER -